Cardiff Lexington Postpones Second Quarter 2025 Earnings Press Release and Investor Call
Cardiff Lexington (OTCQB:CDIX) has announced the postponement of its second quarter 2025 earnings release and investor conference call. The company has not provided a specific new date for the release of its Q2 2025 results but stated it will announce the timing through a press release when determined.
Cardiff Lexington (OTCQB:CDIX) ha annunciato il rinvio della pubblicazione dei risultati del secondo trimestre 2025 e della conference call con gli investitori. La società non ha comunicato una nuova data specifica per la diffusione dei risultati del secondo trimestre 2025, ma ha dichiarato che comunicherà il calendario tramite un comunicato stampa non appena sarà definito.
Cardiff Lexington (OTCQB:CDIX) ha anunciado el aplazamiento de la publicación de resultados del segundo trimestre de 2025 y de la conferencia telefónica con inversores. La compañía no ha proporcionado una nueva fecha concreta para la publicación de los resultados del segundo trimestre de 2025, pero indicó que anunciará el momento mediante un comunicado de prensa cuando se determine.
Cardiff Lexington (OTCQB:CDIX)는 2025년 2분기 실적 발표와 투자자 대상 컨퍼런스콜 연기를 발표했습니다. 회사는 2025년 2분기 실적 발표의 구체적인 새 날짜를 제시하지 않았으나, 결정되는 대로 보도자료를 통해 일정을 공지하겠다고 밝혔습니다.
Cardiff Lexington (OTCQB:CDIX) a annoncé le report de la publication de ses résultats du deuxième trimestre 2025 et de la conférence téléphonique destinée aux investisseurs. La société n'a pas communiqué de nouvelle date précise pour la publication des résultats du deuxième trimestre 2025, mais a indiqué qu'elle annoncerait le calendrier par communiqué de presse une fois celui-ci déterminé.
Cardiff Lexington (OTCQB:CDIX) hat die Verschiebung der Veröffentlichung der Ergebnisse für das zweite Quartal 2025 sowie der Telefonkonferenz für Investoren angekündigt. Das Unternehmen nannte kein konkretes neues Datum für die Veröffentlichung der Ergebnisse des zweiten Quartals 2025, erklärte jedoch, den Zeitpunkt per Pressemitteilung bekanntzugeben, sobald er festgelegt ist.
- None.
- Delay in reporting Q2 2025 financial results indicates potential internal challenges
- Lack of specific timeline for the earnings release creates uncertainty for investors
LEXINGTON, KY / ACCESS Newswire / August 12, 2025 / Cardiff Lexington Corporation (OTCQB:CDIX) today announced that the Company will postpone the announcement of its second quarter 2025 results and investor conference call. The Company will host an investor conference call as soon as practicable in conjunction with the filing of its second quarter 2025 results, the timing of which will be announced via press release at a later date.
About Cardiff Lexington Corporation:
Cardiff Lexington Corporation is a unique targeted healthcare holding company focused on locating, acquiring, and building middle market, niche companies, primarily in Orthopedics, Spine Care, and Pain Management. Fundamental to the Cardiff Lexington strategy is the service-based partnership culture which emphasizes core values, teamwork, accountability, and performance.
A substantial majority of the Company's revenue is derived from Nova Ortho and Spine, LLC, which operates a group of regional primary specialty and ancillary care facilities throughout Florida and Georgia that provide traumatic injury victims with a full range of diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultation services.
For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/
FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's business, the Company's liquidity position, the Company's ability to obtain new business, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.
Use of Non-GAAP Financial Measures
Cardiff Lexington Corporation prepares its consolidated financial statements in accordance with United States generally accepted accounting principles ("GAAP"). In addition to GAAP disclosures, this document contains financial information and measures considered to be "non-GAAP". These non-GAAP measures can be used in order to gain a more complete and accurate understanding of the Company's financial condition and results. Non-GAAP financial measures should be considered in conjunction with, and not as a substitute to GAAP financial measures.
Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705
or
IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200
SOURCE: Cardiff Lexington Corporation
View the original press release on ACCESS Newswire
FAQ
Why did Cardiff Lexington (CDIX) postpone its Q2 2025 earnings release?
When will Cardiff Lexington (CDIX) release its Q2 2025 earnings?
What impact does the earnings delay have on Cardiff Lexington (CDIX) investors?
How can investors access Cardiff Lexington's (CDIX) Q2 2025 earnings call when rescheduled?
